124 related articles for article (PubMed ID: 32339467)
1. Targeting BMPR2 Trafficking with Chaperones: An Important Step toward Precision Medicine in Pulmonary Arterial Hypertension.
Andruska A; Ali MK; Spiekerkoetter E
Am J Respir Cell Mol Biol; 2020 Aug; 63(2):137-138. PubMed ID: 32339467
[No Abstract] [Full Text] [Related]
2. Special delivery: Engineered endothelial cells for pulmonary arterial hypertension.
Chambers DC
Respirology; 2019 Nov; 24(11):1042-1043. PubMed ID: 31426124
[No Abstract] [Full Text] [Related]
3. Letter by Nadeau et al Regarding Article, "Bmpr2 Mutant Rats Develop Pulmonary and Cardiac Characteristics of Pulmonary Arterial Hypertension".
Nadeau V; Bonnet S; Paulin R
Circulation; 2019 Aug; 140(7):e286-e287. PubMed ID: 31403848
[No Abstract] [Full Text] [Related]
4. Response by Mendes-Ferreira et al to Letter Regarding Article, "Bmpr2 Mutant Rats Develop Pulmonary and Cardiac Characteristics of Pulmonary Arterial Hypertension".
Mendes-Ferreira P; Manaud G; Perros F
Circulation; 2019 Aug; 140(7):e288-e289. PubMed ID: 31403844
[No Abstract] [Full Text] [Related]
5. Defective cellular trafficking of the bone morphogenetic protein receptor type II by mutations underlying familial pulmonary arterial hypertension.
John A; Kizhakkedath P; Al-Gazali L; Ali BR
Gene; 2015 Apr; 561(1):148-56. PubMed ID: 25688877
[TBL] [Abstract][Full Text] [Related]
6. Heterozygous null bone morphogenetic protein receptor type 2 mutations promote SRC kinase-dependent caveolar trafficking defects and endothelial dysfunction in pulmonary arterial hypertension.
Prewitt AR; Ghose S; Frump AL; Datta A; Austin ED; Kenworthy AK; de Caestecker MP
J Biol Chem; 2015 Jan; 290(2):960-71. PubMed ID: 25411245
[TBL] [Abstract][Full Text] [Related]
7. Different Cytokine Patterns in BMPR2-Mutation-Positive Patients and Patients With Pulmonary Arterial Hypertension Without Mutations and Their Influence on Survival.
Schwiening M; Swietlik EM; Pandya D; Burling K; Barker P; Feng OY; Treacy CM; Abreu S; Wort SJ; Pepke-Zaba J; Graf S; Marciniak SJ; Morrell NW; Soon E
Chest; 2022 Jun; 161(6):1651-1656. PubMed ID: 35063447
[No Abstract] [Full Text] [Related]
8. Codependence of Bone Morphogenetic Protein Receptor 2 and Transforming Growth Factor-β in Elastic Fiber Assembly and Its Perturbation in Pulmonary Arterial Hypertension.
Tojais NF; Cao A; Lai YJ; Wang L; Chen PI; Alcazar MAA; de Jesus Perez VA; Hopper RK; Rhodes CJ; Bill MA; Sakai LY; Rabinovitch M
Arterioscler Thromb Vasc Biol; 2017 Aug; 37(8):1559-1569. PubMed ID: 28619995
[TBL] [Abstract][Full Text] [Related]
9. Endothelial
Theilmann AL; Hawke LG; Hilton LR; Whitford MKM; Cole DV; Mackeil JL; Dunham-Snary KJ; Mewburn J; James PD; Maurice DH; Archer SL; Ormiston ML
Arterioscler Thromb Vasc Biol; 2020 Nov; 40(11):2605-2618. PubMed ID: 32998516
[TBL] [Abstract][Full Text] [Related]
10. Targeting bone morphogenic protein receptor 2 (BMPR2) signalling to treat pulmonary arterial hypertension.
Rubin LJ
Eur Respir J; 2017 Sep; 50(3):. PubMed ID: 28893872
[No Abstract] [Full Text] [Related]
11. Autophagy contributes to BMP type 2 receptor degradation and development of pulmonary arterial hypertension.
Gomez-Puerto MC; van Zuijen I; Huang CJ; Szulcek R; Pan X; van Dinther MA; Kurakula K; Wiesmeijer CC; Goumans MJ; Bogaard HJ; Morrell NW; Rana AA; Ten Dijke P
J Pathol; 2019 Nov; 249(3):356-367. PubMed ID: 31257577
[TBL] [Abstract][Full Text] [Related]
12. PHorecasting Heritable Pulmonary Arterial Hypertension: Are We Nearly There Yet?
Aldred MA
Am J Respir Crit Care Med; 2020 Dec; 202(11):1500-1502. PubMed ID: 32835509
[No Abstract] [Full Text] [Related]
13. [Pulmonary arterial hypertension in a pedigree with bone morphogenetic protein receptor 2 c.282 mutation].
Song JR; Zhang JW; Li B; Deng MJ; Cao YS
Zhonghua Xin Xue Guan Bing Za Zhi; 2023 Jul; 51(7):769-772. PubMed ID: 37460431
[TBL] [Abstract][Full Text] [Related]
14. Targeting BMPR-II in pulmonary arterial hypertension: a case of Hercules versus the Hydra?
VandenBroek MM; Skebo SI; Ormiston ML
Expert Opin Ther Targets; 2022 Dec; 26(12):1027-1030. PubMed ID: 36638064
[No Abstract] [Full Text] [Related]
15. New pathogenic variant of BMPR2 in pulmonary arterial hypertension.
Yang X; Kong Q; Zhao C; Cai Z; Wang M
Cardiol Young; 2019 Apr; 29(4):462-466. PubMed ID: 30957726
[TBL] [Abstract][Full Text] [Related]
16. Sirtuin 3 and Uncouplin Protein 2, the Missing Link Between Genetics, Metabolism, and Pulmonary Arterial Hypertension.
Lajoie AC; Potus F
J Am Heart Assoc; 2021 Dec; 10(23):e023065. PubMed ID: 34724803
[No Abstract] [Full Text] [Related]
17. Phenotypically Silent Bone Morphogenetic Protein Receptor 2 Mutations Predispose Rats to Inflammation-Induced Pulmonary Arterial Hypertension by Enhancing the Risk for Neointimal Transformation.
Tian W; Jiang X; Sung YK; Shuffle E; Wu TH; Kao PN; Tu AB; Dorfmüller P; Cao A; Wang L; Peng G; Kim Y; Zhang P; Chappell J; Pasupneti S; Dahms P; Maguire P; Chaib H; Zamanian R; Peters-Golden M; Snyder MP; Voelkel NF; Humbert M; Rabinovitch M; Nicolls MR
Circulation; 2019 Oct; 140(17):1409-1425. PubMed ID: 31462075
[TBL] [Abstract][Full Text] [Related]
18. The BMP Receptor 2 in Pulmonary Arterial Hypertension: When and Where the Animal Model Matches the Patient.
Happé C; Kurakula K; Sun XQ; da Silva Goncalves Bos D; Rol N; Guignabert C; Tu L; Schalij I; Wiesmeijer KC; Tura-Ceide O; Vonk Noordegraaf A; de Man FS; Bogaard HJ; Goumans MJ
Cells; 2020 Jun; 9(6):. PubMed ID: 32521690
[No Abstract] [Full Text] [Related]
19. Consequences of BMPR2 Deficiency in the Pulmonary Vasculature and Beyond: Contributions to Pulmonary Arterial Hypertension.
Andruska A; Spiekerkoetter E
Int J Mol Sci; 2018 Aug; 19(9):. PubMed ID: 30149506
[TBL] [Abstract][Full Text] [Related]
20. Gender differences in pulmonary arterial hypertension patients with BMPR2 mutation: a meta-analysis.
Ge X; Zhu T; Zhang X; Liu Y; Wang Y; Zhang W
Respir Res; 2020 Feb; 21(1):44. PubMed ID: 32028950
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
